MyFinsight
Home
Blog
About
Back
Cash Flow
Polaryx Therapeutics, Inc. (PLYX)
Polaryx Therapeutics, Inc. (PLYX)
source: myfinsight.com
Proceeds from issuance of
common stock
$9,831K
Net cash flows
provided by financing...
$9,831K
Net increase
(decrease) in cash and cash...
$8,462K
Canceled cashflow
$1,369K
Prepaid expenses and
other current assets
-$152K
Accrued expenses
related party
$28K
Net cash flows used
in operating...
-$1,369K
Canceled cashflow
$180K
Net loss
-$1,380K
Accounts payable
-$167K
Due to related party
-$2K
Back